Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct 1;160(10):1128-1130.
doi: 10.1001/jamadermatol.2024.2993.

Incidence and Prevalence of Morphea

Heejo Keum  1 , Henry W Chen  1 , Robert W Haley  2   3 , Heidi T Jacobe  1
Affiliations

Incidence and Prevalence of Morphea

Heejo Keum et al. JAMA Dermatol. .
No abstract available

Plain language summary

This cohort study uses population-based data to estimate the incidence and prevalence of morphea in the US among patients of all ages.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: None reported.

Figures

Figure.
Figure.. Incidence and Prevalence Rates of Morphea by Age Group From the TriNetX US Collaborative Network and IBM MarketScan Commercial Claims and Encounters Databases
A, Error bars indicate 95% CIs. Values are missing for age groups older than 64 years from the MarketScan data because their medical insurance plan did not cover the Medicare age group.
See this image and copyright information in PMC

References

    1. Peterson LS, Nelson AM, Su WP, Mason T, O’Fallon WM, Gabriel SE. The epidemiology of morphea (localized scleroderma) in Olmsted County 1960-1993. J Rheumatol. 1997;24(1):73-80. - PubMed
    1. Beukelman T, Xie F, Foeldvari I. The prevalence of localised scleroderma in childhood assessed in the administrative claims data from the United States. J Scleroderma Relat Disord. 2019;4(1):77-78. doi: 10.1177/2397198318798588 - DOI - PMC - PubMed
    1. Herrick AL, Ennis H, Bhushan M, Silman AJ, Baildam EM. Incidence of childhood linear scleroderma and systemic sclerosis in the UK and Ireland. Arthritis Care Res (Hoboken). 2010;62(2):213-218. doi: 10.1002/acr.20070 - DOI - PubMed
    1. van den Hoogen F, Khanna D, Fransen J, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League Against Rheumatism Collaborative initiative. Ann Rheum Dis. 2013;72(11):1747-1755. doi: 10.1136/annrheumdis-2013-204424 - DOI - PubMed
    1. Ferreli C, Gasparini G, Parodi A, Cozzani E, Rongioletti F, Atzori L. Cutaneous manifestations of scleroderma and scleroderma-like disorders: a comprehensive review. Clin Rev Allergy Immunol. 2017;53(3):306-336. doi: 10.1007/s12016-017-8625-4 - DOI - PubMed